DalsnaFinance › IPOs › Seres Therapeutics › IPO
Seres Therapeutics, Inc. completed its initial public offering on NASDAQ on June 26, 2015, pricing at $18.00 a share.
| Ticker | MCRB |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 26, 2015 |
| Offering price | $18.00 |
| Shares offered | 7,430,555 |
| Total raised | $134M |
Seres Therapeutics, Inc. sold 7,430,555 shares at $18.00 each on NASDAQ. Multiplied out, that is $133.7 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $134 million total recorded for the deal.
Seres Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Seres Therapeutics, Inc.. This page is general information, not investment advice.